Product Information

KERENDIA 40 MG TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $22.8554 per EA under NDC 50419054202. Its NADAC has been published 39 times since Feb 18, 2026.

FDA first approved this application on Jul 9, 2021.

KERENDIA 40 MG TABLET

finerenone
$22.8554per EA

Strength

40 mg/1

NDC

50419054202

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FINERENONE

Approval Type

New Drug (NDA)

FDA Application

NDA215341

FDA Approved

7/9/2021

On Market Since

7/9/2021

Pharmacological Classes

Mineralocorticoid Receptor Antagonists
Nonsteroidal Mineralocorticoid-Receptor Antagonist

Price Statistics

The NADAC for KERENDIA 40 MG TABLET has been published 39 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$22.8554 per EA
All-time high$22.8957 (Sep 16, 2026)
All-time low$22.8554 (Oct 21, 2026)
52-week high$22.8957
52-week low$22.8554
Median price$22.8643
Average price$22.8730
Largest weekly change-0.1% (Sep 23, 2026)
Weeks tracked39
Tracking sinceFeb 18, 2026

Price History

1W

0.0%

1M

-0.0%

3M

-0.2%

6M

-0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KERENDIA 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for KERENDIA 40 MG TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $22.8554 per EA (NDC 50419054202), effective Nov 11, 2026.

How has the price of KERENDIA 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for KERENDIA 40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 39 weekly CMS publications since Feb 18, 2026.

What are the highest and lowest recorded NADAC prices for KERENDIA 40 MG TABLET?

Since Feb 18, 2026, the NADAC for KERENDIA 40 MG TABLET has ranged from a low of $22.8554 (Oct 21, 2026) to a high of $22.8957 (Sep 16, 2026), with a median of $22.8643 per EA.

Are there cheaper alternatives to KERENDIA 40 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KERENDIA 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures KERENDIA 40 MG TABLET?

KERENDIA 40 MG TABLET (NDC 50419054202) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.